- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 12.05. | FDA follows EMA in limiting use of Valneva shot | ||
| 12.05. | Trump revives 'most favored nation' plan in effort to cut US drug prices | ||
| 12.05. | Abeona sells speedy drug review voucher for $155M | ||
| 12.05. | Innovating a healthier tomorrow: Entering a new era of medicine | ||
| 12.05. | [Podcast] Behind the Breakthroughs: How Almac Powers Clinical Trial Success with Care | ||
| 09.05. | Eli Lilly extends Purdue alliance; EMA investigates Valneva shot | ||
| 08.05. | 4 more biotechs cut staff amid market tumult | ||
| 08.05. | Viatris' new form of old pain drug scores in large trials | ||
| 08.05. | Gilead, bracing for tariffs, joins peers in US drug production push | ||
| 08.05. | Biotech is guessing how Vinay Prasad might change the FDA. His research, writing offer clues. | ||
| 08.05. | Haya banks $65M to scour the 'dark genome' for new drugs | ||
| 07.05. | FDA set to meet this month on COVID vaccines | ||
| 07.05. | Novo cuts forecasts as compounded GLP-1s weigh on sales | ||
| 07.05. | Sarepta shares plummet as lower sales outlook adds to gloom over FDA's new biologics hire | ||
| 06.05. | Prasad's FDA appointment pressures cell and gene therapy stocks | ||
| 06.05. | Vinay Prasad, a physician and FDA critic, to lead agency center overseeing vaccines | ||
| 06.05. | Facing 'uncertainty on steroids,' biotech dealmakers tread more cautiously | ||
| 06.05. | Trump orders FDA to help speed building of new drug factories | ||
| 06.05. | Bluebird pleads for deal support; Unity, Mersana lay off staff | ||
| 05.05. | PTC stock slides on new data for Huntington's drug | ||
| 05.05. | AI specialist Recursion trims pipeline in latest shakeup | ||
| 05.05. | Deerfield secures more than $600M for its next biotech venture fund | ||
| 02.05. | Amgen's Stelara biosimilar gets off to fast start | ||
| 02.05. | Cytokinetics reveals unexpected delay; AstraZeneca combo therapy hits in asthma | ||
| 01.05. | Moderna combination flu, COVID shot delayed amid FDA scrutiny |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .